Lawmakers in Maryland are daring to legislate where theirfederal counterparts have not: As of Oct. 1, the state will be ableto say “no” to some pharmaceutical price spikes.

A new law, which focuses on generic and off-patent drugs,empowers the state’s attorney general to step in if a drug’s priceclimbs 50 percent or more in a single year. Thecompany must justify the hike. If the attorney general stillfinds the increase unwarranted, he or she can file suit in statecourt. Manufacturers face a fine of up to $10,000 for pricegouging.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events
  • Access to other award-winning ALM websites including and

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.